Voyager Therapeutics (VYGR) Treasury Shares (2014 - 2026)

Voyager Therapeutics has disclosed Treasury Shares across 13 years of filings, most recently posting $2.1 million for Q1 2026.

• Treasury Shares for Q1 2026 came in at $2.1 million, down 25.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 million (down 25.99% YoY), and the FY2025 annual result was $2.3 million, up 39.21% from the prior year.
• Treasury Shares came in at $2.1 million for Q1 2026 at Voyager Therapeutics, down from $2.3 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.8 million in Q1 2025 to a low of $941275.0 in Q3 2022.
• The 5-year median for Treasury Shares is $1.6 million (2024), against an average of $1.7 million.
• Across the five-year window, Treasury Shares slumped 31.7% in 2022 and soared 65.72% in 2025, its largest moves.
• Voyager Therapeutics' Treasury Shares stood at $1.1 million in 2022, then gained by 23.22% to $1.4 million in 2023, then increased by 20.35% to $1.6 million in 2024, then jumped by 39.21% to $2.3 million in 2025, then retreated by 8.2% to $2.1 million in 2026.
• The last three Treasury Shares figures came in at $2.1 million (Q1 2026), $2.3 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.